ORKA-001

· Oruka Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ORKA-001, covering 2026-03-17 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis [Phase 2]